Diacont

The company "Diakont" conducts research and is engaged in the production of medical devices for patients with diabetes mellitus.

History

2022: Production start-up

On October 24, 2022, it became known about the launch by Diakont of the production of test strips, glucose meters, glucose sensors and insulin pumps for monitoring blood sugar levels intended for patients with diabetes mellitus. Investments in the project are estimated at 1 billion rubles, it is being implemented with the assistance of the Moscow Region Development Corporation (KRMO).

The project will be divided into several stages. The first of them involves the launch of the production of test strips, the second - the launch of a workshop for the production of glucose meters, sensors of glucose biosensors and insulin pumps. The new production will be equipped with modern high-tech equipment, which will allow the production of up to 300 million packages of products per year, said Ekaterina Zinovieva, Deputy Prime Minister - Minister of Investment, Industry and Science of the Moscow Region.

The production of medical devices for diabetics is being launched in the Moscow region

The founders of the company, together with employees of the Department of Moscow State University and the Pushchinsky Scientific Center for Biological Research of the Russian Academy of Sciences, developed a method for determining glucose, which formed the basis for the creation of test strips and glucometers designed to determine blood sugar levels in 2003.

In parallel with the launch of the production of test strips, Diakont organizes at the enterprise the production of raw materials for its products - graphite paste and biosynthesis of glucose oxidase and glucose enzymes - dehydrogenase. For this, a special laboratory is equipped at the enterprise. Test strips will be produced in a Class 7 clean room in accordance with ISO 13485. For the production of glucose sensors and insulin pumps - electronic-mechanical devices that continuously supply insulin from a special reservoir to subcutaneous fat tissue, a separate workshop will be built.

Our company has always had a small production in Russia and the main enterprise in Southeast Asia, where we produce more than 750 million packages of products per year. Now we have decided to make a complete localization in Russia. The very process of production of test strips in recent years has stepped forward. It is not difficult to launch such production, but the only question is that all our competitors use imported materials in 99%, "said Peter Shishko, General Director of Diakont.[1]

The release medical devices will be launched on the territory of the urban district Queens in January 2023. At the first stage, about 20 jobs will be created at the enterprise, in the future the company plans to increase the staff to 500 people. The small production of the Diakont company is already operating in Korolev in October 2022 and produces up to 15 thousand packages of finished products per year.

Notes

Шаблон:Remarks